Compare PSTV & KXIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PSTV | KXIN |
|---|---|---|
| Founded | 1996 | 2015 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Retail-Auto Dealers and Gas Stations |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 61.1M | 4.7M |
| IPO Year | N/A | N/A |
| Metric | PSTV | KXIN |
|---|---|---|
| Price | $0.63 | $5.27 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $7.25 | N/A |
| AVG Volume (30 Days) | ★ 6.2M | 1.5M |
| Earning Date | 10-30-2025 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $5,258,000.00 | $95,000.00 |
| Revenue This Year | $28.21 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.16 | $2.94 |
| 52 Week High | $2.31 | $75.00 |
| Indicator | PSTV | KXIN |
|---|---|---|
| Relative Strength Index (RSI) | 52.79 | 64.44 |
| Support Level | $0.61 | $3.32 |
| Resistance Level | $0.76 | $5.40 |
| Average True Range (ATR) | 0.05 | 0.85 |
| MACD | 0.01 | 0.14 |
| Stochastic Oscillator | 38.12 | 77.55 |
Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).
Kaixin Holdings is an auto retail platform for luxury used cars and imported new cars. The company is actively engaged in the research and development, design, manufacturing, and sales of electric vehicles and promotes the innovation of next-generation autonomous driving and artificial intelligence technologies. The company generates revenues from sales of used cars, as well as fees obtained from its role as a channel partner for third-party auto financing and other value-added service providers.